CYP4A11 and nonpapillary renal cell carcinoma: Our results demonstrate that CYP4A11 metabolism is different between ccRCC and non-ccRCCs and might be useful as a predictive diagnostic factor for ccRCC and for the development of a potential therapeutic target.